Skip to main content

Anthony O. Edozien, MD

Academic Title:

Assistant Professor

Primary Appointment:



IHV, S316

Phone (Primary):




Education and Training


1980 BA (history) Yale University, New Haven, CT
1985 BA (philosophy) Insitut St. Pierre Canisius, Kinshasa, Zaire
1989 MDiv (incomplete) Weston School of Theology
1990 Pre-Med University of North Carolina, Chapel Hill, NC
1994 MD University of North Carolina, Chapel Hill, NC
2004 MPH (incomplete) University of North Carolina School of Public Health

Residency (Internal Medicine/Pediatrics):

1994-1998 Internal Medicine/Pediatrics, Tulane Medical Center, New Orleans, LA

Fellowship (Infectious Disease):

2000-2004 Infectious Disease, University of North Carolina, Chapel Hill, NC


As an infectious disease specialist, Dr. Edozien is capable of preventing, diagnosing, and treating a wide variety of infectious diseases. Typically, patients with an infectious disease, such as malaria, will require highly specialized treatment or care. Dr. Edozien may also educate patients traveling to places around the world that have a high rate of infectious diseases; this is sometimes referred to as travel medicine. 

The specialty of internal medicine is an area of primary care for adults. Dr. Edozien specializes in diagnosing and treating cross-system illnesses that may affect multiple organ systems. He may also refer patients to specialist physicians when medically needed. For instance, patients with serious heart problems could be referred to a cardiologist for further diagnostic tests or therapies. 

Research/Clinical Keywords

Infectious Disease, HIV, Infection

Highlighted Publications

Trends in Congenital Syphilis in the US 2000-2002, MMWR 2004; 53: 716-719

Ritonavir-Boosted Atazanavir May Be Efficacious in HIV-Infected Patients Concurrently Receiving Omeprazole, Clinical Infectious Diseases 2006;42:1344–1344

Lamivudine Monotherapy in an HIV-Infected Patient With the M184V Mutation, Journal of the International Association of Physicians: AIDS Care 5(3); 2006 pp. 121-122

Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression, JAIDS Journal of Acquired Immune Deficiency Syndromes: 1 April 2006 - Volume 41 - Issue 4 - pp 531-532

Controversial approaches in HIV infection : Is there a role for lopinavir/ritonavir monotherapy?, Infections in medicine; 2006, vol. 23, no8: 342-351

Amoroso A, Etienne-Mesubi M, Edozien A, Ojoo S, Sheneberger R, Obiefune M, Hossian M, Stafford K, Redfield RR. Treatment Outcomes of Recommended First Line Antiretroviral Regimens in Resource Limited Clinics. JAIDS 1 July 2012-Volume 60, Issue 3, p 314-320

Sowah, LA; Turenne, F; Buchwald; Delva, G; Mesidor, RN; Dessaigne, CG; Previl, H; Patel, D; Edozien, A; Redfield, RR; Amoroso, A. Influence of Transportation Cost on Long-term Retention in a Clinic for HIV Patients in Rural Haiti, JAIDS 2014;67:e123–e130

Awards and Affiliations

1999: Board Certified, Pediatrics
1998: Board Certified, Internal Medicine
2004: Board Eligible, Infectious Disease Medicine
2016: Recertification, Internal Medicine